A shadow economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Experimental Treatment Gaining Popularity Online
The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a robust trade exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and assertions of rapid UK delivery. Sellers promote the drug there before redirecting customers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Experts Voice Concerns
However, physicians and pharmacists have cautions that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.
Several experts said the demand for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.
Regulatory Position and Implementation
Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, legal action or prison.
Platform Response and Material Removal
According to TikTok, the service has removed problematic content and prohibited related hashtags and query recommendations. The company stated it was committed to maintaining the platform safe and investing in enhancing compliance measures.
Digital Trading Operations
Investigations also found communities with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, filled with images of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at residence.
Within minutes of joining one community, a vendor posted contact information, where the majority of transactions take place. The seller sent an guidebook and guaranteed shipping within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.
Product Details and Costs
Within these communities, messages show dark colored packages with postal service labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually priced at £160 for 20 milligrams. When questioned how long a pen should last, sellers give conflicting responses ranging from a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram stated it regularly moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering substances they can’t verify. Even if the research behind this drug is sound, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent cost increases for approved slimming medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has already seen patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to potentially significant health risks”.
